NEWZ - ETF AI Analysis
Top Page
StockSnips AI-Powered Sentiment US All Cap ETF (NEWZ)
NEWZ, the StockSnips AI-Powered Sentiment US All Cap ETF, earns a solid overall rating thanks to several strong holdings like Arista Networks, Nu Holdings, and Medpace, which all show robust financial performance, positive earnings sentiment, and growth exposure to areas like AI, cloud, and expanding payments markets. The fund is held back somewhat by weaker names such as McKesson and Concentra Group, where leverage, profitability, and operational challenges create added risk, and a key overall risk factor is that many top holdings appear richly valued or overbought, which could increase volatility if market sentiment shifts.
NEWZ vs. SPDR S&P 500 ETF (SPY)
- AUM
- 21.23M
- Region
- North America
- Expense Ratio
- 0.75%
- Beta
- 0.79
- Issuer
- StockSnips
- Inception Date
- Apr 12, 2024
- Dividend Yield
- 0.27%
- Asset Class
- Equity
- Index Tracked
- No Underlying Index
NEWZ Summary
NEWZ is the StockSnips AI-Powered Sentiment US All Cap ETF, focused on the total U.S. stock market. Instead of tracking a traditional index, it uses artificial intelligence to read news and gauge investor sentiment, then invests across large, mid, and small companies in many sectors like technology, financials, and utilities. Well-known holdings include Meta Platforms and Mastercard. Someone might invest in NEWZ for broad diversification and the potential growth from an AI-driven stock selection approach. A key risk is that its stock prices, and the AI strategy itself, can go up and down with changing market news and sentiment.
How much will it cost me?
The StockSnips AI-Powered Sentiment US All Cap ETF (Ticker: NEWZ) has an expense ratio of 0.75%, which means you’ll pay $7.50 per year for every $1,000 invested. This is higher than average because the fund is actively managed and uses advanced AI technology to analyze market sentiment, which requires more resources and expertise.
What would affect this ETF?
The NEWZ ETF, with its focus on U.S. equities and heavy exposure to technology and healthcare sectors, could benefit from advancements in AI, innovation in tech, and increased demand for healthcare services. However, it may face challenges from rising interest rates, regulatory changes affecting AI or healthcare, and economic slowdowns that impact consumer spending and industrial growth.
NEWZ Top 10 Holdings
NEWZ is leaning heavily into AI and tech-related winners, with Nvidia, Arista Networks, and TSMC acting as the fund’s main engines, all showing rising momentum thanks to the ongoing AI and semiconductor boom. Medpace and Penumbra add a steady health care tilt, helping smooth out volatility. On the flip side, Corpay and Marex are more mixed, occasionally dragging on returns despite solid long-term stories. While the ETF is U.S.-focused, it sneaks in global flavor through names like TSMC and Sumitomo Mitsui, giving the portfolio a subtle international twist.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
 CPAY | Corpay Inc | 3.90% | $827.84K | $26.25B | 44.09% | 75Outperform |
 NU | Nu Holdings | 3.78% | $802.55K | $70.33B | -1.15% | 79Outperform |
 MCK | McKesson | 3.66% | $776.94K | $117.15B | 29.58% | 62Neutral |
 CON | Concentra Group Holdings Parent, Inc. | 3.54% | $751.52K | $4.91B | 93.67% | 66Neutral |
 HCA | HCA Healthcare | 3.46% | $734.61K | $99.34B | 9.35% | 70Neutral |
 CART | Maplebear | 3.46% | $734.02K | $11.54B | 27.80% | 79Outperform |
 MRX | Marex Group plc | 3.45% | $732.18K | $5.07B | 135.63% | 73Outperform |
 CI | Cigna | 3.40% | $722.22K | $79.88B | 3.86% | 72Outperform |
 CB | Chubb | 3.40% | $721.10K | $138.81B | 34.13% | 80Outperform |
 COKE | Coca-Cola Bottling Co Consolidated | 3.39% | $719.20K | $14.00B | 61.06% | 72Outperform |
NEWZ Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For NEWZ, the sentiment is Neutral. The current price of 29.62 is above the 20-day moving average (MA) of 29.53, below the 50-day MA of 29.89, and above the 200-day MA of 28.92, indicating a neutral trend. The MACD of -0.00 indicates Negative momentum. The RSI at 49.12 is Neutral, neither overbought nor oversold. The STOCH value of 51.05 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for NEWZ.
NEWZ Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| NEWZ | $29.62 | $33.00(11.41% Upside) | $21.23M | 0.75% | 74Outperform |
 BAMD | $33.74 | $37.98(12.57% Upside) | $97.25M | 0.87% | 70Outperform |
 STNC | $36.93 | $42.79(15.86% Upside) | $92.23M | 0.85% | 68Neutral |
 SOVF | $31.34 | $37.57(19.91% Upside) | $89.56M | 0.75% | 70Neutral |
 PFOE | $22.25 | $28.83(29.61% Upside) | $89.52M | 0.59% | 72Outperform |
 VAMO | $35.69 | $42.32(18.56% Upside) | $86.37M | 0.65% | 63Neutral |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| NEWZ | StockSnips AI-Powered Sentiment US All Cap ETF | 29.62 | 0.97 | 3.37% | |
| BAMD | Brookstone Dividend Stock ETF | 33.74 | 3.70 | 12.31% | |
| STNC | Stance Equity ESG Large Cap Core ETF | 36.93 | 4.05 | 12.33% | |
| SOVF | Sovereign's Capital Flourish Fund | 31.34 | 1.58 | 5.31% | |
| PFOE | Pathfinder Focused Opportunities ETF | 22.25 | -2.61 | -10.50% | |
| VAMO | Cambria Value & Momentum ETF | 35.69 | 2.77 | 8.41% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.